These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine. Borrelli E; Battista M; Cascavilla ML; Viganò C; Borghesan F; Nicolini N; Clemente L; Sacconi R; Barresi C; Marchese A; Miserocchi E; Modorati G; Bandello F; Querques G Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):28. PubMed ID: 34581725 [TBL] [Abstract][Full Text] [Related]
23. Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy. Lee MG; Kim SJ; Ham DI; Kang SW; Kee C; Lee J; Cha HS; Koh EM Invest Ophthalmol Vis Sci; 2014 Nov; 56(1):396-402. PubMed ID: 25425304 [TBL] [Abstract][Full Text] [Related]
24. Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity. Adam MK; Covert DJ; Stepien KE; Han DP Br J Ophthalmol; 2012 May; 96(5):723-9. PubMed ID: 22328813 [TBL] [Abstract][Full Text] [Related]
25. Implementation of recommendations for the screening of hydroxychloroquine retinopathy: poor adherence of rheumatologists and ophthalmologists. Shulman S; Wollman J; Brikman S; Padova H; Elkayam O; Paran D Lupus; 2017 Mar; 26(3):277-281. PubMed ID: 27440459 [TBL] [Abstract][Full Text] [Related]
26. Macular sensitivities measured by microperimetry in patients on hydroxychloroquine treatment. Eren M; Kucukevcilioglu M; Durukan AH Cutan Ocul Toxicol; 2018 Sep; 37(3):275-280. PubMed ID: 29495877 [TBL] [Abstract][Full Text] [Related]
27. New trends in early diagnosis of hydroxychloroquine toxic retinopathy. Vanderzee G; Tassi D Optometry; 2012 May; 83(5):200-7. PubMed ID: 23249122 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of Retromode Imaging for Use in Hydroxychloroquine Retinopathy. Ahn SJ; Lee SU; Lee SH; Lee BR Am J Ophthalmol; 2018 Dec; 196():44-52. PubMed ID: 30118686 [TBL] [Abstract][Full Text] [Related]
30. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy. Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364 [TBL] [Abstract][Full Text] [Related]
31. Early retinal and retinal nerve fiber layer effects of hydroxychloroquine: a follow up study by sdOCT. Yülek F; Uğurlu N; Akçay E; Kocamış Sİ; Gerçeker S; Erten Ş; Midillioğlu İ; Şimşek Ş Cutan Ocul Toxicol; 2013 Sep; 32(3):204-9. PubMed ID: 23351071 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of hydroxychloroquine retinopathy with long-term use in a cohort of Indian patients with rheumatic diseases. Manoj M; Sahoo RR; Singh A; Hazarika K; Bafna P; Kaur A; Wakhlu A Rheumatol Int; 2021 May; 41(5):929-937. PubMed ID: 33704526 [TBL] [Abstract][Full Text] [Related]
33. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. Lai TY; Chan WM; Li H; Lai RY; Lam DS Am J Ophthalmol; 2005 Nov; 140(5):794-807. PubMed ID: 16310457 [TBL] [Abstract][Full Text] [Related]